ONCE-A-DAY SINGULAIR
SINGULAIR is easy to take. You simply take 1 pill once a day in the evening. And you can take it with or without food. As with most asthma controller medicines, SINGULAIR must be taken every day for as long as the doctor prescribes, whether or not you have asthma symptoms.
SINGULAIR is not a steroid.
SINGULAIR comes in 4 easy-to-take forms:
- A 4-mg oral granules packet (for children 12–23 months old)
- A 4-mg cherry chewable tablet (for children 2–5 years old)
- A 5-mg cherry chewable tablet (for children 6–14 years old)
- A 10-mg tablet that you swallow whole (for adults and adolescents 15 years and older)
Tablets and packet may not be shown at actual size.
IMPORTANT SAFETY INFORMATION (continued)
- SINGULAIR may cause serious side effects. Behavior and mood-related changes have been reported: agitation including aggressive behavior or hostility, bad or vivid dreams, depression, disorientation (confusion), feeling anxious, hallucinations (seeing or hearing things that are not really there), irritability, restlessness, sleepwalking, suicidal thoughts and actions (including suicide), tremor, and trouble sleeping. Tell your healthcare provider right away if you have, or your child has, any of these symptoms while taking SINGULAIR.
- The most common side effects with SINGULAIR include upper respiratory infection, fever, headache, sore throat, cough, stomach pain, diarrhea, earache or ear infection, flu, runny nose, and sinus infection.
- Parents or guardians of a child with phenylketonuria: Note that cherry chewable tablets contain phenylalanine, a component of aspartame.
- SINGULAIR should not be taken by people who are sensitive to any of its ingredients.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please read the Patient Information and discuss it with your healthcare provider.
The physician Prescribing Information also is available.
This site is intended only for residents of the United States, its territories, and Puerto Rico.
For non-US health care professionals, click here.






